concentration are large as compared with their normal range of values. Errors in the interpretation of these results are potentially important, for example in the followup of patients with the nephrotic syndrome or cirrhosis. We recommend that, when the precise result is of importance, the patient's posture on each occasion should be the same for the 20 mm before venepuncture. Table 1 shows effect on plasma corticotropin determinations of adding N-ethylmaleimide to whole blood. Corticotropin decreased as a function of time whether or not the inhibitor was present, but the decrease was less at all times in the samples containing N-ethylmaleimide.
Results
Differences were statistically significant only at 0 and 1 h. The mean decrease from initial corticotropin values with N-ethylmaleimide was 37% at 1 h and 41% at 24 h.
In contrast, Figure 1 
Discussion
As have others (4), we found that corticotropin is more stable in plasma than in whole blood. Although N-ethylmaleimide slowed its degradation in whole blood, an average of 41% became nonreactive within 24 h. On the other hand, destruction of corticotropin in plasma at room temperature is prevented by N-ethylmaleimide for at least 72 h. The mechanism of action of the inhibitor is uncertain, but it possibly simply reflects inactivation of proteolytic enzymes (2) . Addition of N-ethylmaleimide to samples for plasma corticotropin assay would obviate the problem of destruction of the hormone during collection and shipping, and thus make plasma corticotropin determination more practical and reli-
